galantamine hydrobromide extended release capsules 16mg bulk
alphapharm pty ltd - galantamine hydrobromide, quantity: 20.512 mg - capsule, modified release - excipient ingredients: magnesium stearate; povidone; hydrogenated vegetable oil; colloidal anhydrous silica; sodium lauryl sulfate; polyvinyl acetate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; titanium dioxide; allura red ac; potable water; gelatin
galantamine hydrobromide extended release capsules 8mg bulk
alphapharm pty ltd - galantamine hydrobromide, quantity: 10.256 mg - capsule, modified release - excipient ingredients: magnesium stearate; povidone; hydrogenated vegetable oil; titanium dioxide; allura red ac; potable water; gelatin; sodium lauryl sulfate; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; colloidal anhydrous silica; polyvinyl acetate
mylan-galantamine er capsule (extended release)
mylan pharmaceuticals ulc - galantamine (galantamine hydrobromide) - capsule (extended release) - 8mg - galantamine (galantamine hydrobromide) 8mg - parasympathomemetic (cholinergic) agents
acumor xl 8mg capsules
viatris uk healthcare ltd - galantamine hydrobromide - modified-release capsule - 8mg
galantamine sr ch galantamine (as hydrobromide) 24mg modified release capsules blister pack
southern cross pharma pty ltd - galantamine hydrobromide, quantity: 30.756 mg (equivalent: galantamine, qty 24 mg) - capsule, modified release - excipient ingredients: iron oxide yellow; microcrystalline cellulose; iron oxide red; gelatin; ethylcellulose; hypromellose; magnesium stearate; titanium dioxide; indigo carmine; erythrosine - galantamine is indicated for the treatment of mild to moderately severe dementia of the alzheimer type
galantamine sr ch galantamine (as hydrobromide) 16mg modified release capsules blister pack
southern cross pharma pty ltd - galantamine hydrobromide, quantity: 20.504 mg (equivalent: galantamine, qty 16 mg) - capsule, modified release - excipient ingredients: iron oxide red; ethylcellulose; titanium dioxide; hypromellose; gelatin; magnesium stearate; microcrystalline cellulose - galantamine is indicated for the treatment of mild to moderately severe dementia of the alzheimer type
galantamine sr ch galantamine (as hydrobromide) 8mg modified release capsules blister pack
southern cross pharma pty ltd - galantamine hydrobromide, quantity: 10.252 mg (equivalent: galantamine, qty 8 mg) - capsule, modified release - excipient ingredients: magnesium stearate; ethylcellulose; titanium dioxide; hypromellose; gelatin; microcrystalline cellulose - galantamine is indicated for the treatment of mild to moderately severe dementia of the alzheimer type
galantamine sr scp galantamine (as hydrobromide) 24mg modified release capsules blister pack
southern cross pharma pty ltd - galantamine hydrobromide, quantity: 30.756 mg (equivalent: galantamine, qty 24 mg) - capsule, modified release - excipient ingredients: iron oxide yellow; microcrystalline cellulose; iron oxide red; gelatin; ethylcellulose; hypromellose; magnesium stearate; titanium dioxide; indigo carmine; erythrosine - galantamine is indicated for the treatment of mild to moderately severe dementia of the alzheimer type
galantamine sz galantamine (as hydrobromide) 16mg modified release capsules blister pack
southern cross pharma pty ltd - galantamine hydrobromide, quantity: 20.504 mg (equivalent: galantamine, qty 16 mg) - capsule, modified release - excipient ingredients: hypromellose; gelatin; ethylcellulose; microcrystalline cellulose; iron oxide red; titanium dioxide; magnesium stearate - galantamine is indicated for the treatment of mild to moderately severe dementia of the alzheimer type
galantamine sr scp galantamine (as hydrobromide) 16mg modified release capsules blister pack
southern cross pharma pty ltd - galantamine hydrobromide, quantity: 20.504 mg (equivalent: galantamine, qty 16 mg) - capsule, modified release - excipient ingredients: iron oxide red; ethylcellulose; titanium dioxide; hypromellose; gelatin; magnesium stearate; microcrystalline cellulose - galantamine is indicated for the treatment of mild to moderately severe dementia of the alzheimer type